News from Pharma Times, Feb 24 2014

Industry concern over EU pharmacovigilance fees

“The European Federation of Pharmaceutical Industries and Associations (EFPIA), the European Generic medicines Association (EGA), the European biotech industry (EuropaBio), the Association of the European Self-Medication Industry (AESGP) and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) have issued a joint statement about their concerns for “the increasing financial burden of regulatory costs incurred since the adoption of the pharmacovigilance package in 2010″….”